Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Cited by (1,010)

Items 1,001–1,010 of 1,010

1. The complex roles of efferocytosis in cancer development, metastasis, and treatment
   Tajbakhsh, Amir, Gheibi hayat, Seyed Mohammad, Movahedpour, Ahmad, Savardashtaki, Amir, Loveless, Reid, Barreto, George E., Teng, Yong, Sahebkar, Amirhossein · 2021 · Biomedicine & Pharmacotherapy
2. Dendritic cells as cancer therapeutics
   Bryant, Christian E., Sutherland, Sarah, Kong, Benjamin, Papadimitrious, Michael S., Fromm, Phillip D., Hart, Derek N.J. · 2019 · Seminars in Cell & Developmental Biology
3. Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer
   Deng, Siyao, Vlatkovic, Tijana, Li, Moying, Zhan, Tianzuo, Veldwijk, Marlon R., Herskind, Carsten · 2022 · Cancers
4. Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
   Petrazzuolo, Adriana, Perez-Lanzon, Maria, Martins, Isabelle, Liu, Peng, Kepp, Oliver, Minard-Colin, Véronique, Maiuri, Maria Chiara, Kroemer, Guido · 2021 · Cell Death & Disease
5. Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients
   Buttarelli, Marianna, Ciucci, Alessandra, Palluzzi, Fernando, Raspaglio, Giuseppina, Marchetti, Claudia, Perrone, Emanuele, Minucci, Angelo, Giacò, Luciano, Fagotti, Anna, Scambia, Giovanni et al. · 2022 · Journal of Experimental & Clinical Cancer Research
6. Sialoside-based pattern recognitions discriminating infections from tissue injuries
   Liu, Yang, Chen, Guo-Yun, Zheng, Pan · 2011 · Current Opinion in Immunology
7. ALICE: a randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer
   Kyte, J. A., Røssevold, A., Falk, R. S., Naume, B. · 2020 · Journal of Translational Medicine
8. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a “Hot” Tumor Microenvironment That Is Responsive to Immunotherapy
   Reschke, Robin, Olson, Daniel · 2022 · Cancers
9. Autocrine and Paracrine Purinergic Signaling in the Most Lethal Types of Cancer
   Reyna-Jeldes, M., Díaz-Muñoz, M., Madariaga, J. A., Coddou, C., Vázquez-Cuevas, F. G. · 2021 · Purinergic Signalling
10. Efferocytosis in dendritic cells: an overlooked immunoregulatory process
    Ma, Yanyan, Jiang, Tangxing, Zhu, Xun, Xu, Yizhou, Wan, Ke, Zhang, Tingxuan, Xie, Miaorong · 2024 · Frontiers in Immunology